Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-11

Clinical Trial Update: A Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism [NA]

View source ↗

Summary

Clinical trial evaluating selenomethionine and myo-inositol (SOLOWAYS) in autoimmune thyroiditis patients carrying the DIO2 Thr92Ala polymorphism has completed.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Myo-inositol (myo-inositol)
  • Selenomethionine (selenomethionine)

Snippet

Sponsor: S.LAB (SOLOWAYS) | Conditions: Autoimmune Thyroiditis | NA | Status: COMPLETED